About this trial
The purpose of this study is to gather information about patient experience receiving a massage through a robotic EMMA (Expert Manipulative Massage Automation) compared to receiving a massage from a massage therapist.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
be 18 years of age or older.
report a primary pain point in the lower back.
Pain intensity reported at baseline
Women of childbearing potential who self-report not being pregnant and agree to employ an effective method of birth control (surgical sterilization or oral contraceptives, barrier method with spermicides, intrauterine device, etc.) during the study period
Disqualifiers
Pregnancy or breastfeeding
Patients with the inability to stay in a prone position
Patients with bleeding disorders
Patients with allergies and/or local skin affectations
Trial design
Parallel
Treatments tested in this trial
EMMA massage therapy
DeviceExpert Manipulative Massage Automation (EMMA) is equipped with sensors to measure muscle stiffness and uses 3D vision technology to measure muscle stiffness and identify pressure points while delivering a massage to patients. Following that, the electronic massager will determine the best course of action for our patients based on the information stored by our Artificial Intelligence and EMMA's robotic arm will perform the massage. EMMA executes massages through soft treatment modules that are warmed to a temperature of between 38℃ and 40℃ to mimic human touch.
Clinical massage treatment
Other interventionThe direct person clinical massage treatment will be delivered by a clinical licensed massage therapist. The type of massage will follow the EMMA massage in that it will be a deep tissue massage (to mimic the Tuina massage) and generally will be for about 30 minutes to once again mimic the duration of massage therapy of the EMMA.
Treatment groups
Trial outcomes
Primary outcomes
Number of patients enrolled
Feasibility will be determined by the total number of patients screened in order to accrue the 40 needed to complete the study.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.